Addiction

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS withdrawal · 2021-11-16
Clinical Trial Update: Dopaminergic Modulation of Frontostriatal Function With a Dopamine Agonist and COMT Inhibitor [Phase 4]
Phase 4 trial investigating dopaminergic modulation of frontostriatal function with a dopamine agonist and COMT inhibitor for addiction was …